The Weekly Roundup

December 03, 2016 | Pamela Youngberg Dickson

This week, the 21st Century Cures Act sailed through the House and is headed to the Senate next week. The legislation will invest more than $6 billion in public health and medical research over the next decade. The bill, nearly 1,000 pages long, scratches at various funding mechanisms for medical research, revamps the FDA approval process, and would fund hundreds of vacant job requisitions at the agency, which has struggled to attract qualified candidates with competitive offers.

While it has substantial bipartisan support, there remain several highly vocal detractors, like Senator Elizabeth Warren, who refers to the bill as a Big Pharma giveaway and a danger to the public, and Dr. Michael Carome, director of Public Citizen’s Health Research Group, who said he was concerned about provisions that will allow for summaries of study data rather than full clinical trial records, which he believes could 
"hide important information about the safety and effectiveness from the FDA scientist reviewing the data.”

But supporters point to what they describe as overwhelming benefits: faster time-to-market for drugs and devices, mental health reforms, and monies toward battling the opioid epidemic and Vice President Joe Biden’s “moonshot” project to cure cancer.

Here are few other stories that might be of interest:

[Editor’s note:] Our inboxes are stuffed with newsletters and our coffee tables stacked with magazines and industry digests. I’m sure yours are, too. So we’ve decided to run a weekly sampling of interesting stories, issues coverage, and business ideas we come across each week. We hope you’ll share some of your favorites, too. Drop us a line at

Alzheimer's CancerFDALegislation

Pamela Youngberg Dickson

Before she came to Smart-Fill, Pamela developed marketing strategy and content for a range of technology start-ups and large-cap enterprises. Outside the office, she's into gardening, renaissance history, the Big Ten, and exploring the great outdoors.